203 related articles for article (PubMed ID: 27641332)
1. ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
Talamillo A; Grande L; Ruiz-Ontañon P; Velasquez C; Mollinedo P; Torices S; Sanchez-Gomez P; Aznar A; Esparis-Ogando A; Lopez-Lopez C; Lafita C; Berciano MT; Montero JA; Vazquez-Barquero A; Segura V; Villagra NT; Pandiella A; Lafarga M; Leon J; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
Oncogene; 2017 Mar; 36(12):1733-1744. PubMed ID: 27641332
[TBL] [Abstract][Full Text] [Related]
2. HIF2α Upregulates the Migration Factor ODZ1 under Hypoxia in Glioblastoma Stem Cells.
Carcelén M; Velásquez C; Vidal V; Gutierrez O; Fernandez-Luna JL
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054927
[No Abstract] [Full Text] [Related]
3. Glioblastoma invasion factor ODZ1 is induced by microenvironmental signals through activation of a Stat3-dependent transcriptional pathway.
Vidal V; Gutierrez O; Talamillo A; Velasquez C; Fernandez-Luna JL
Sci Rep; 2021 Aug; 11(1):16196. PubMed ID: 34376733
[TBL] [Abstract][Full Text] [Related]
4. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells.
Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
[TBL] [Abstract][Full Text] [Related]
5. RANBP10 promotes glioblastoma progression by regulating the FBXW7/c-Myc pathway.
Hou J; Liu Y; Huang P; Wang Y; Pei D; Tan R; Zhang Y; Cui H
Cell Death Dis; 2021 Oct; 12(11):967. PubMed ID: 34671019
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia Can Induce Migration of Glioblastoma Cells Through a Methylation-Dependent Control of
Velásquez C; Mansouri S; Gutiérrez O; Mamatjan Y; Mollinedo P; Karimi S; Singh O; Terán N; Martino J; Zadeh G; Fernández-Luna JL
Front Oncol; 2019; 9():1036. PubMed ID: 31649891
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
8. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue.
Ruiz-Ontañon P; Orgaz JL; Aldaz B; Elosegui-Artola A; Martino J; Berciano MT; Montero JA; Grande L; Nogueira L; Diaz-Moralli S; Esparís-Ogando A; Vazquez-Barquero A; Lafarga M; Pandiella A; Cascante M; Segura V; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
Stem Cells; 2013 Jun; 31(6):1075-85. PubMed ID: 23401361
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
10. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
11. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
12. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
[TBL] [Abstract][Full Text] [Related]
13. YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity.
Yu OM; Benitez JA; Plouffe SW; Ryback D; Klein A; Smith J; Greenbaum J; Delatte B; Rao A; Guan KL; Furnari FB; Chaim OM; Miyamoto S; Brown JH
Oncogene; 2018 Oct; 37(41):5492-5507. PubMed ID: 29887596
[TBL] [Abstract][Full Text] [Related]
14. HPCAL1 promotes glioblastoma proliferation via activation of Wnt/β-catenin signalling pathway.
Zhang D; Liu X; Xu X; Xu J; Yi Z; Shan B; Liu B
J Cell Mol Med; 2019 May; 23(5):3108-3117. PubMed ID: 30843345
[TBL] [Abstract][Full Text] [Related]
15. EZH2 is essential for glioblastoma cancer stem cell maintenance.
Suvà ML; Riggi N; Janiszewska M; Radovanovic I; Provero P; Stehle JC; Baumer K; Le Bitoux MA; Marino D; Cironi L; Marquez VE; Clément V; Stamenkovic I
Cancer Res; 2009 Dec; 69(24):9211-8. PubMed ID: 19934320
[TBL] [Abstract][Full Text] [Related]
16. Girdin maintains the stemness of glioblastoma stem cells.
Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
[TBL] [Abstract][Full Text] [Related]
17. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
[TBL] [Abstract][Full Text] [Related]
18. The transcript ENST00000444125 of lncRNA LINC01503 promotes cancer stem cell properties of glioblastoma cells via reducing FBXW1 mediated GLI2 degradation.
Wei P; Jiang J; Xiao M; Zeng M; Liu X; Zhao B; Chen F
Exp Cell Res; 2022 Mar; 412(1):113009. PubMed ID: 34990616
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Released by Glioblastoma Cells Stimulate Normal Astrocytes to Acquire a Tumor-Supportive Phenotype Via p53 and MYC Signaling Pathways.
Hallal S; Mallawaaratchy DM; Wei H; Ebrahimkhani S; Stringer BW; Day BW; Boyd AW; Guillemin GJ; Buckland ME; Kaufman KL
Mol Neurobiol; 2019 Jun; 56(6):4566-4581. PubMed ID: 30353492
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Respiratory Factor 1 (NRF1) Transcriptional Activity-Driven Gene Signature Association with Severity of Astrocytoma and Poor Prognosis of Glioblastoma.
Bhawe K; Felty Q; Yoo C; Ehtesham NZ; Hasnain SE; Singh VP; Mohapatra I; Roy D
Mol Neurobiol; 2020 Sep; 57(9):3827-3845. PubMed ID: 32594352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
